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Abstract
Background: Large controversy exists regarding the potential existence and clinical significance of larger brain
volumes in toddlers who later develop autism. Assessing this relationship is important for determining the clinical
utility of early head circumference (HC) measures and for assessing the validity of the early overgrowth hypothesis
of autism, which suggests that early accelerated brain development may be a hallmark of the disorder.
Methods: We performed a retrospective comparison of HC, height, and weight measurements between 66
toddlers who were later diagnosed with autism and 66 matched controls. These toddlers represent an unbiased
regional sample from a single health service provider in the southern district of Israel. On average, participating
toddlers had >8 measurements between birth and the age of two, which enabled us to characterize individual HC,
height, and weight development with high precision and fit a negative exponential growth model to the data of
each toddler with exceptional accuracy.
Results: The analyses revealed that HC sizes and growth rates were not significantly larger in toddlers with autism
even when stratifying the autism group based on verbal capabilities at the time of diagnosis. In addition, there
were no significant correlations between ADOS scores at the time of diagnosis and HC at any time-point during
the first 2 years of life.
Conclusions: These negative results add to accumulating evidence, which suggest that brain volume is not
necessarily larger in toddlers who develop autism. We believe that conflicting results reported in other studies are
due to small sample sizes, use of misleading population norms, changes in the clinical definition of autism over
time, and/or inclusion of individuals with syndromic autism. While abnormally large brains may be evident in some
individuals with autism and more clearly visible in MRI scans, converging evidence from this and other studies
suggests that enlarged HC is not a common etiology of the entire autism population. Early HC measures, therefore,
offer very limited clinical utility for assessment of autism risk in the general population.
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Background
Early brain overgrowth is one of the most prominent
contemporary theories of autism development [1–3]. Ac-
cording to the theory, autism may be caused by different
genetic predispositions and/or environmental insults
that accelerate cellular proliferation, migration, differen-
tiation, and development so as to generate abnormally
large brains during the first 2 years of life. Early acceler-
ated growth is thought to be followed by arrested
growth, which explains why adolescents and adults with
autism do not have larger brain volumes [4]. Neverthe-
less, the availability of head circumference (HC) as a bio-
marker during early development could be extremely
useful for identifying toddlers at risk of developing aut-
ism even before the onset of behavioral symptoms [2].
Since HC is an excellent correlate of brain volume dur-
ing the first years of life [5], testing whether toddlers
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with autism indeed exhibit early brain overgrowth is a
relatively straight forward venture.
Previous studies have reported that toddlers who later
develop autism are born with normal HC and then de-
velop abnormally large HC during the first 2 years of life
[6–10]. These findings have been corroborated by post
mortem [11] and MRI [12–16] studies that have re-
ported significantly larger brains in toddlers who develop
autism. Later studies, however, have questioned whether
early overgrowth is specific to the brain or reflects gen-
eral body overgrowth as apparent also in height and
weight measurements [17]. Furthermore, the validity of
early findings that were mostly based on comparisons
with CDC population norms have been questioned, be-
cause these norms have underestimated the true HC dis-
tribution in the general population [18]. With this in
mind, several comparisons of early HC measurements
between toddlers with autism and community-matched
controls did not find any significant between-group dif-
ferences [19–23]. These studies demonstrate the ongoing
controversy regarding the existence and clinical signifi-
cance of early brain overgrowth in toddlers with autism.
When interpreting the studies above, it is important to
consider the sample characteristics in each case. For ex-
ample, it has been suggested that larger brain volumes
may be more strongly associated with specific autism
etiologies involving regression [24], immunological in-
sults [25], and specific genetic abnormalities (e.g., PTEN
mutations [26]). Furthermore, HC is hereditary regardless
of autism [27]. Differences in genetics and the environ-
mental exposures of the examined sample as well as the
inclusion/exclusion criteria of each study may, therefore,
have an impact on potential differences across autism and
control groups. For example, contrary to previous reports
from the USA [28], assessment of large clinical databases
in Norway and Israel reported modest [22] or no [29] dif-
ferences in the rates of macrocephaly (HC >97% of the
general population) in children diagnosed with autism.
To further address these issues, we performed a retro-
spective assessment of HC measurements that were re-
corded at birth and between the ages of 1–24 months at
Maccabi Healthcare infant wellness centers in the south-
ern district of Israel. The collected data included, on
average, >8 HC, weight, and height measurements from
each of the 66 toddlers who were later diagnosed with
idiopathic autism and the 66 community-matched con-
trols. This data contained approximately twice as many
samples per toddler in comparison to previous studies.
The large number of samples enabled us to examine the
longitudinal HC development of individual toddlers with
high temporal resolution and fit a negative exponential
growth model to the data of each toddler with remark-
able accuracy. In addition, we examined the potential re-
lationship between early HC measures and autism
severity measures at the time of diagnosis as assessed by
the Autism Diagnostic Observation Schedule (ADOS;
[30]). Importantly, the examined data represents an un-
biased community sample of the members of Maccabi
Healthcare services who make up approximately one
third of the population in southern Israel.
Methods
Participants
We collected retrospective HC, weight, and height data
from electronic patient records of children who were di-
agnosed with autism at the Maccabi Child Development
Center in Beer Sheva (n = 66, 60 boys). The autism
group included 22 children who were diagnosed accord-
ing to DSM-IV criteria (17 with autism, 4 with PDD-
NOS, and 1 with Asperger’s syndrome) and 44 children
who were diagnosed according to DSM-V criteria and
received a formal diagnosis of autism spectrum disorders
(ASD). Diagnosis was confirmed in the first group of 22
children using the first [30] edition of the ADOS and in
the later 44 children using the second [31] edition of the
ADOS. The mean age of diagnosis was 36.94 months
(standard deviation 13 months). Each child with autism
was matched, in terms of gender and date of birth
(±30 days), with a typically developing control child
from the same southern Maccabi Healthcare district
(Table 1). Children with known chromosomal disorders,
known genetic disorders (e.g., RETT), hydrocephalus,
additional developmental and neurological disorders,
and those born before 36 weeks of gestation or below
2 kg were excluded from the study.
Head circumference, weight, and height data
We extracted all of the available HC, weight, and height
measurements from the electronic patient records of
each child. All of the measurements were performed by
nurses at Maccabi Healthcare Infant Wellness Centers,
except for the measurement at birth, which was con-
ducted by a midwife. Both the nurses and the midwives
Table 1 Sample characteristics including the number of
toddlers (relative number of females), the term in weeks, ADOS
and ADI scores, age at diagnosis, and number of HC samples
available from the individual patient records
Autism Control
Number of toddlers (females) 66 (6) 66 (6)
Term in weeks (range) 39.1 (36–42) 39.5 (36.2–41.5)
ADOS total (range) 16.1 (7–26)
ADOS severity score (range) 7 (4–10)
ADI-R (range) 18 (7–26)
Age at diagnosis (range) 3 (1–5.3) years
Number of HC samples 8.3 (4–12) 8.4 (4–12)
Range of the sample is in parentheses
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perform dozens of HC, weight, and height measure-
ments every week and are extremely proficient in this
work. The mean number of measurements per toddler
was 8.3 (SD 2.1) in the ASD group and 8.42 (SD 1.74) in
the control group (range 4–12 samples per child in both
groups). There were no significant differences in the
number of measurements across ASD and control
groups (t (125) = −0.48, p = 0.6, two-tailed t test). In
Israel, all children are invited to visit a baby clinic at the
ages of 1, 2, 4, 6, 9, 12, 15, 18, and 24 months to
complete standard check-ups and immunizations as part
of the free social health care services. The final number
of visits/measurements and the precise age of the visits,
however, depend on parental compliance.
Data analyses
Analyses were performed with custom written code in
Matlab (Mathworks Inc., USA). Since each child had
measurements at different time-points within the first
24 months of life, we first linearly interpolated the mea-
surements into vectors with a time resolution of weeks
using the interp1 function in Matlab. This enabled us to
estimate the week-by-week HC, weight, and height
values of each child from the age of their first measure-
ment to the age of their last measurement without as-
suming an overall growth model with a predefined shape
(Fig. 1). We then compared HC, weight, and height of
children who later developed autism and controls while
binning the data into 3-month intervals from birth to
the age of 24 months. We used two-tailed two-sample
t tests with unequal variances to assess the signifi-
cance of differences across groups. We also computed
the Pearson’s correlation coefficient between ADOS
severity scores (see below) and HC measurements for
each of the age intervals (bins) described above. The
significance of the correlation coefficients was not
corrected for multiple comparisons in order to in-
crease sensitivity.
ADOS calibrated severity scores (also known as “Com-
parison Score”) were calculated using the ADOS-2 algo-
rithm [31] in children who were diagnosed by the
ADOS-2 (n = 44) or an alternative algorithm [32] avail-
able for children who were diagnosed with the first ver-
sion of ADOS (n = 22).
We used a negative exponential growth model (Matlab
code is available in the Additional file 1) that was used
in previous HC studies of autism [19] to estimate the
rate of HC growth in each toddler during the first 2 years
of life:
HC ¼ αþ β−αð Þ  e−γ x
The model describes a nonlinear function where α
represents the asymptote (a maximum size for growth
within the time frame considered), β represents the
intercept at age 0 (i.e., birth), and γ represents the anti-
log of the rate of change (growth rate from birth to the
asymptote). The three parameters were estimated for
each of the toddlers. We used the same model to exam-
ine weight and height growth as well. We tested for
group differences by performing two-tailed t tests with
unequal variances for each of the model parameters. The
significance of differences across groups was not cor-
rected for multiple comparisons in order to increase
sensitivity.
Fig. 1 Head circumference, weight, and height measurements from the 66 toddlers who later developed autism (blue) and the 66 matched
controls (red). Each line represents the development of a single toddler as estimated with linear interpolation between measurement points
(see “Methods”)
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Results
Individual development curves
On average, there were >8 HC, height, and weight mea-
surements available for each toddler in our sample. The
precise number of measurements and their relative tim-
ing (i.e., toddler’s age at each measurement), however,
varied across toddlers. To overcome these differences
across toddlers, we performed a linear interpolation over
time, connecting pairs of datapoints with straight lines.
In this manner, we built a growth curve for each toddler
with a temporal resolution of weeks (Fig. 1). This en-
abled us to examine the developmental changes in HC,
weight, and height of individual toddlers from each of
the groups throughout their first 2 years of life. All three
measures exhibited the typical logarithmic shape, and
the distribution of individual values was qualitatively
similar across the two groups (Fig. 1). Note the high-
resolution of these linearly interpolated growth curves,
which is a feature of the large number of samples ob-
tained from each toddler (see “Methods”).
Comparisons across autism and control groups
Mean growth curves of the two groups were overlapping
for all three measures (Fig. 2, top row). We tested
whether there were any differences across groups at
multiple ages between birth and 24 months in 3-month
intervals. Note that height is not measured at birth in
Israel; hence, comparisons of this measure start from the
age of 3 months. The control group exhibited signifi-
cantly larger head circumference and weight at birth and
at 3 months of age (p < 0.05, t > 2.1, uncorrected to
increase sensitivity, Fig. 2, bottom row). All other
between-group comparisons did not reveal any statisti-
cally significant differences across groups (see Table 2).
Note that with 66 toddlers in each group, our sample
size yields a power of 0.88 for detecting larger HC
measures in the autism group (assuming an effect
size of 0.5).
Comparison of growth model parameters
We fit a nonlinear growth model (see “Methods”), which
contained three parameters: intercept, rate of change,
and asymptote, to the data of each toddler (Fig. 3). In
agreement with the results described above, control tod-
dlers exhibited significantly larger intercept (β) values
when modeling HC (p = 0.02, t = 2.3, Fig. 3b) or weight
(p = 0.007, t = 2.8, Fig. 3c) measures. The significant dif-
ference in the intercept indicates that HC and weight
measures were significantly larger in control toddlers at
birth. The two other parameters did not differ across
groups for any of the measures. The lack of difference in
rate of change indicates that there were no significant
growth rate differences between autism and control
toddlers in any of the measures. Note that the model
fit the data of individual toddlers extremely well,
explaining >94% of the variance in all cases, for all
three measures (R2 values in Fig. 3).
Performing the same analysis only with male toddlers
produced equivalent results: control toddlers exhibited
significantly larger intercept (β) values when modeling HC
Fig. 2 Comparison of HC, weight, and height across autism (blue) and control (red) groups. Top row: Mean of each group as a function of age in
weeks. Shaded area: standard deviation across toddlers. Bottom row: Mean of each group in 3-month periods. Error bars: standard error of the
mean across subjects. Red asterisks: significantly larger values in the control group (p < 0.05, uncorrected to increase sensitivity)
Dinstein et al. Molecular Autism  (2017) 8:15 Page 4 of 9
(p = 0.03, t = 2.2) or weight measures (p = 0.01, t = 2.5),
and there were no significant differences across groups in
the rate of change and asymptote parameters.
Head circumference and autism severity
We examined the potential relationships between HC as
measured at specific ages and autism severity as quanti-
fied by the ADOS total score or calibrated severity score
(see “Methods”) at the time of diagnosis. All of the cor-
relations were weak and not statistically significant
indicating that HC measures were not associated with
ADOS scores (Fig. 4).
Verbal and nonverbal toddlers
We performed the same HC comparisons described
above (Fig. 2), while separating nonverbal toddlers who
were diagnosed with the toddler module (n = 14) or
module 1 (n = 36) of the ADOS from the verbal toddlers
who were diagnosed with module 2 (n = 15) of the
ADOS. Significantly larger HC was apparent in the con-
trol group at 3 months of age in comparison to the aut-
ism toddlers diagnosed with module 1 (p = 0.008, t = 2.7,
two-tailed t test, uncorrected to increase sensitivity) and
at 24 months of age in comparison to the autism tod-
dlers diagnosed with module 2 (p < 0.04, t > 2.4, two-
tailed t test, uncorrected to increase sensitivity). All
other differences between autism and control groups
were not significant (Fig. 5). This indicates that early HC
measures are not larger in children who later develop
autism regardless of their verbal abilities at time of
diagnosis.
Discussion
Our results demonstrate that toddlers diagnosed with
autism in southern Israel do not exhibit early HC over-
growth during the first 2 years of life. Comparisons with
control toddlers who were born at equivalent times and
geographical locations revealed that HC, weight, and
height measurements were mostly indistinguishable
from those of toddlers with autism during the first
24 months of development and, if anything, were larger
in the control group at birth and 3 months of age (Figs. 1
and 2). Furthermore, growth parameters estimated using
a nonlinear negative exponential model were not signifi-
cantly different across groups except for the intercept
parameter, which indicated significantly larger HC and
weight measures in the control group at birth (Fig. 3).
Equivalent findings were evident when examining only
male toddlers and when splitting toddlers with autism
into verbal and nonverbal groups according to the
ADOS modules used for diagnosis (Fig. 5). Finally, HC
during the first 24 months of development did not pre-
dict later autism severity at the time of diagnosis (Fig. 4).
An important strength of the current study lies in the
relatively large number of measurements that were ex-
tracted from each of our 132 participants. While most
previous studies relied on 3–4 HC samples per child, we
extracted >8 HC, weight, and height measurements per
toddler, on average. This enabled us to estimate HC,
weight, and height growth rates with exceptional accur-
acy as reflected in the goodness-of-fits of individual tod-
dlers (>94% of the variance explained in all toddlers,
Fig. 3). Furthermore, each of the 66 toddlers with autism
was closely matched to a control toddler who was born
Table 2 Comparisons of HC, weight, and height across groups
from birth to the age of 24 months in 3-month intervals
Head circumference
Age Autism Control Autism-control t value p value
Birth 34.4 35 −0.6 −2.1 0.04*
3 months 39.7 40.2 −0.5 −2.8 0.006*
6 months 42.8 43.2 −0.4 −1.7 0.1
9 months 44.7 44.9 −0.2 −1.3 0.19
12 months 45.9 46.2 −0.3 −1.3 0.21
15 months 46.7 47.1 −0.4 −1.7 0.1
18 months 47.2 47.7 −0.5 −1.9 0.06
21 months 47.7 48.3 −0.6 −1.4 0.17
24 months 48.1 49.1 −1 −1.8 0.12
Weight
Age Autism Control Autism-control t value p value
Birth 3.2 3.4 −0.2 −2.7 0.007*
3 months 5.6 6.1 −0.5 −3.8 0.0004*
6 months 7.6 7.9 −0.3 −1.9 0.06
9 months 8.7 9 −0.3 −1.4 0.1
12 months 9.7 9.9 −0.2 −1.2 0.24
15 months 10.4 10.6 −0.2 −0.9 0.36
18 months 11.1 11.3 −0.2 −1 0.31
21 months 11.7 12 −0.3 −1.1 0.28
24 months 12.3 12.5 −0.2 −1 0.31
Height
Age Autism Control Autism-control t value p value
3 months 59.4 60 −0.6 −1.9 0.06
6 months 66.9 67.3 −0.4 −1.2 0.24
9 months 71.5 71.8 −0.3 −1.4 0.58
12 months 75.5 75.3 0.2 −1.2 0.73
15 months 78.8 78.5 0.3 −0.9 0.53
18 months 81.7 81.5 0.2 −1 0.72
21 months 84.5 84.2 0.3 −1.1 0.63
24 months 87 86.7 0.3 −1 0.67
HC and height are in centimeters and weight is in kilograms. Columns: mean
of the autism group, mean of the control group, the difference between
autism and control groups, t values, and p values from a two-tailed two-
sample t test with unequal variance. p values are not corrected to
increase sensitivity Asterisks: p value < 0.05
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within 30 days in the same geographical location. This
ensured that the examined HC, weight, and height mea-
surements were collected by similarly trained clinical
staff within the same local community. Hence, the
growth rates presented in the current study are likely to
represent the true distribution of rates in the autism and
control populations of southern Israel.
Fig. 3 Comparison of head growth modeling parameters across autism (blue) and control (red) groups. Demonstration of HC growth model fits
in individual toddlers: asterisks represent measurements and the lines represent the model fits (a). Boxplots demonstrating the HC (b), weight (c),
and height (d) growth parameters: asymptote (α), intercept (β), and rate of change (γ) in each group. Red asterisks: significantly larger parameter
values in the control group. R2: box plots demonstrating the model fits of individual toddlers in each group for each of the measures
Fig. 4 Relationship between HC at specific ages and ADOS score at
time of diagnosis. Pearson’s correlation coefficients were computed for
HC and total ADOS (gray) scores or calibrated ADOS scores (black)
Fig. 5 Comparison of HC at specific ages when separating the
autism group according to ADOS modules. Mean HC in toddlers
with autism diagnosed with the toddler module (dark blue), module
1 (medium blue), or module 2 (light blue), and control toddlers (red).
Error bars: standard error of the mean across toddlers in each group.
Asterisks: significantly larger HC in the control group as compared
with that in the autism group of the corresponding color (p < 0.05,
uncorrected to increase sensitivity)
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HC overgrowth in autism
Previous studies have reported that HC is enlarged in
autism during the first 2 years of life [6–10, 12, 17].
Analogous studies have reported significantly higher
rates of macrocephaly (HC >97% of the general popula-
tion) in children with autism [33–35]. While many of
the HC and macrocephaly studies described above were
biased by the use of misleading population norms pub-
lished by the CDC [18], some studies have reported sig-
nificantly larger HC in autism, even in comparisons with
control toddlers from the same community [12, 17].
This evidence is often cited in support of the prominent
early overgrowth theory of autism, which suggests that
autism may be caused by abnormal cellular proliferation,
migration, and differentiation that generate accelerated
brain growth during the first 2 years of life [1–3].
In contrast to the studies described above, a growing
body of literature has reported that HC measures during
the first 2 years of life are not significantly larger in tod-
dlers who later develop autism [19–23]. Similarly, recent
assessments of large clinical databases in Norway and
Israel have reported modest [22] or no [29] difference in
macrocephaly rates between autism and control popula-
tions. Our results are in line with these later studies and
present further evidence for a lack of difference across
groups in both HC size and growth rate during the first
2 years of life.
We believe that the conflicting results between older
studies that reported significant HC differences across
groups and more recent studies that do not may be ex-
plained by several key reasons: First, many of the earlier
studies compared HC measurements from toddlers with
autism to outdated and misleading CDC norms that
underestimated the true HC distribution of the general
population in the USA [18]. Second, earlier studies, even
if they included matched controls, were based on small
samples of 20–30 individuals in each group while more
recent studies and the current one were based on sam-
ple sizes that were at least twice as large. Given the large
variability in HC across individuals of each group (Figs. 1
and 2), studies with larger samples are more likely to
yield accurate estimates of the HC distributions in each
group, which are necessary for assessing differences
across groups [4]. Third, older studies may have in-
cluded subjects with known genetic syndromes in com-
parison to more recent studies that exclude such
individuals. Since syndromal subtypes of autism are spe-
cifically associated with macrocephaly (e.g., tuberous
sclerosis [36] and PTEN mutations [26]), it is possible
that some of the older studies may have included rare
participants with extreme HC measures.
Another potential reason for conflicting findings
across older and newer studies is the ongoing change in
clinical criteria of autism diagnoses, which have led to a
considerable increase in autism prevalence [37]. For ex-
ample, recent samples of children with autism are likely
to include children with milder forms of autism and/or
higher cognitive function [38] as well as children who
would have received a mental retardation diagnosis in
the past [39]. While we did not find a relationship be-
tween early HC measures and autism severity at the age
of diagnosis (Fig. 4), an older study did report such a re-
lationship [9]. In addition, given the dramatic increase in
autism prevalence, current samples of children with aut-
ism are likely to contain more biological heterogeneity
and relatively fewer syndromic cases of autism.
Environmental and genetic factors associated with HC
growth
HC growth rates are dependent on a wide variety of en-
vironmental and genetic factors, regardless of autism.
For example, HC growth is associated with the richness of
postnatal nutrition [40], pre-natal exposure to a variety of
substances including folic acid [41] and acrylamide [42],
and maternal stress levels during pregnancy [43]. Genetic
risk factors include polymorphisms and mutations in a
variety of genes such as PTEN and CHD8 [44]. Further-
more, HC is highly heritable regardless of autism and is
highly correlated with genetic ancestry [27].
This means that the utility of early HC measures for
clinical assessment of autism risk depends on whether
findings are generalizable across multiple populations
with distinct genetics and environmental exposures. The
negative findings in this study and those of a recent
macrocephaly study in the Israeli population [29] suggest
that HC is, at the very least, a poor predictor of autism
risk in the Israeli population. The equivalent negative re-
sults reported in studies from North America [19–21]
and Europe [22], however, suggest that our findings are
not due to genetic and/or environmental factors that are
unique to Israel. A clearer understanding of how brain
overgrowth differs in samples with distinct genetic and
environmental factors is, therefore, critical for further
evaluating the clinical utility of early HC measures in
specific sub-groups of children with autism.
The overgrowth hypothesis of autism
HC is obviously a very coarse measure for testing the
overgrowth hypothesis of autism. MRI scans offer far
more detailed and accurate measures of total brain vol-
ume while enabling separation of gray and white matter
volumes and assessment of cortical thickness and surface
area. While such measures do not differ significantly be-
tween autism and control subjects who are over the age
of six [4], toddlers with autism may exhibit larger brain
volumes during the second year of life in comparison to
controls [12–16]. Furthermore, specific overgrowth of
cortical surface area may be apparent even during the
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first year of life in those who later develop autism [16].
Additional evidence from diffusion tensor imaging (DTI)
studies suggests that toddlers with autism exhibit abnor-
mal white matter microstructure, which may indicate
early over-proliferation of neurons [45, 46] as also found
in several post mortem studies [11, 47].
While specific neuroimaging measures of brain over-
growth may indeed differ between individuals with aut-
ism and controls during early development, converging
evidence seems to suggest that HC measures do not cap-
ture these differences in a reliable manner during the
first 2 years of life. This is unfortunate because neuroim-
aging studies are expensive and examine small samples
that are usually biased (i.e., usually include parents who
have the time, motivation, and capabilities to bring their
children to the MRI center). In contrast, HC studies are
cheaper and enable assessment of larger unbiased sam-
ples from the general population by examining HMO
databases.
Conclusions
Given the large heterogeneity of mechanisms that have
been implicated in the development of autism [48], it is
not surprising that there are mixed reports regarding the
existence of HC differences across autism and control
groups in different studies/samples. Indeed, similarly con-
flicting reports exist with respect to many physiological
and behavioral measures studied in individuals with autism
[49]. The great challenge facing contemporary autism re-
search is to define specific sub-groups of toddlers with aut-
ism who exhibit specific etiologies. While early brain
overgrowth may embody one such etiology, it is likely to
be relevant to particular syndromic forms of autism and to
specific individuals who exhibit abnormally large brain vol-
umes early in life. Future research regarding early over-
growth would, therefore, benefit from targeted studies with
these particular individuals rather than attempting to asso-
ciate early overgrowth with the entire autism population.
Additional file
Additional file 1: Matlab code for fitting the negative exponential
growth model. (DOCX 15 kb)
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